DCP Capital, a private equity firm established by KKR’s former heads of China in 2019, is set to acquire the owner of sports nutrition, body-building protein powders and supplements brands Vitaco Health Group.
Vitaco’s Chinese owners, Primavera Capital and Shanghai Pharmaceuticals, have agreed to sell the business for around $450 million. Barclays and Barrenjoey Capital Partners advised Primavera and Shanghai Pharmaceuticals, while Lazard tended to DCP Capital.
Loading…
